Robert S Wilson1, Lei Yu2, Sue E Leurgans2, David A Bennett2, Patricia A Boyle2. 1. From the Departments of Neurological Sciences (R.S.W., L.Y., S.E.L., D.A.B.) and Behavioral Sciences (R.S.W., P.A.B.), Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL. rwilson@rush.edu. 2. From the Departments of Neurological Sciences (R.S.W., L.Y., S.E.L., D.A.B.) and Behavioral Sciences (R.S.W., P.A.B.), Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL.
Abstract
OBJECTIVE: To estimate the proportion of late-life cognitive loss attributable to impending death. METHODS: Older persons (n = 1,071) in a longitudinal cohort study without dementia at enrollment underwent annual cognitive assessments (mean 10.6 years, SD 4.6, range 4-24) prior to death. We estimated the onset of terminal acceleration in cognitive decline and rates of decline before and after this point in change point models that allowed calculation of the percent of cognitive loss attributable to terminal decline. Outcomes were composite measures of global and specific cognitive functions. We also estimated dementia and mild cognitive impairment (MCI) incidence before and during the terminal period. RESULTS: A mean of 3.7 years before death (95% credible interval [CI] -3.8 to -3.5), the rate of global cognitive decline accelerated to -0.313 unit per year (95% CI -0.337 to -0.290), a more than 7-fold increase indicative of terminal decline. The mean global cognitive score dropped 0.377 unit (SD 0.516) assuming no terminal decline and 1.192 units (SD 1.080) with terminal decline. As a result, 71% (95% bootstrapped CI 0.70, 0.73) of overall global cognitive loss was terminal. In subsequent analyses, terminal decline accounted for 70% of episodic memory loss, 65% of semantic memory loss, 57% of working memory loss, 52% of perceptual speed loss, and 53% of visuospatial loss. MCI incidence in the preterminal and terminal periods was similar, but dementia incidence was more than 6-fold higher in the terminal period than preterminal. CONCLUSION: Most late-life cognitive loss is driven by terminal decline.
OBJECTIVE: To estimate the proportion of late-life cognitive loss attributable to impending death. METHODS: Older persons (n = 1,071) in a longitudinal cohort study without dementia at enrollment underwent annual cognitive assessments (mean 10.6 years, SD 4.6, range 4-24) prior to death. We estimated the onset of terminal acceleration in cognitive decline and rates of decline before and after this point in change point models that allowed calculation of the percent of cognitive loss attributable to terminal decline. Outcomes were composite measures of global and specific cognitive functions. We also estimated dementia and mild cognitive impairment (MCI) incidence before and during the terminal period. RESULTS: A mean of 3.7 years before death (95% credible interval [CI] -3.8 to -3.5), the rate of global cognitive decline accelerated to -0.313 unit per year (95% CI -0.337 to -0.290), a more than 7-fold increase indicative of terminal decline. The mean global cognitive score dropped 0.377 unit (SD 0.516) assuming no terminal decline and 1.192 units (SD 1.080) with terminal decline. As a result, 71% (95% bootstrapped CI 0.70, 0.73) of overall global cognitive loss was terminal. In subsequent analyses, terminal decline accounted for 70% of episodic memory loss, 65% of semantic memory loss, 57% of working memory loss, 52% of perceptual speed loss, and 53% of visuospatial loss. MCI incidence in the preterminal and terminal periods was similar, but dementia incidence was more than 6-fold higher in the terminal period than preterminal. CONCLUSION: Most late-life cognitive loss is driven by terminal decline.
Authors: Patricia A Boyle; Robert S Wilson; Lei Yu; Alasdair M Barr; William G Honer; Julie A Schneider; David A Bennett Journal: Ann Neurol Date: 2013-07-10 Impact factor: 10.422
Authors: Robert S Wilson; Lisa L Barnes; Kristin R Krueger; George Hoganson; Julia L Bienias; David A Bennett Journal: J Int Neuropsychol Soc Date: 2005-07 Impact factor: 2.892
Authors: Xiaoping Lin; Jane Banaszak-Holl; Jing Xie; Stephanie A Ward; Henry Brodaty; Elsdon Storey; Raj C Shah; Anne Murray; Joanne Ryan; Suzanne G Orchard; Sharyn M Fitzgerald; John J McNeil Journal: J Am Geriatr Soc Date: 2021-09-17 Impact factor: 5.562
Authors: Shahram Oveisgharan; Ana W Capuano; Alifiya Kapasi; Aron S Buchman; Julie A Schneider; David A Bennett; Zoe Arvanitakis Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.160
Authors: Lindsay M K Wallace; Olga Theou; Sultan Darvesh; David A Bennett; Aron S Buchman; Melissa K Andrew; Susan A Kirkland; John D Fisk; Kenneth Rockwood Journal: Neurology Date: 2020-09-28 Impact factor: 9.910
Authors: Patricia A Boyle; Tianhao Wang; Lei Yu; Robert S Wilson; Robert Dawe; Konstantinos Arfanakis; Julie A Schneider; Todd Beck; Kumar B Rajan; Denis Evans; David A Bennett Journal: Alzheimers Dement Date: 2021-06-01 Impact factor: 16.655